The NHS in England is all set to offer patients a new form of medicine, gene silencing, in an injection called inclisiran. NHS will be undertaking a large-scale clinical trial later this year. The initiative could save 30,000 lives during the next decade. Inclisiran 'silences' a particular gene and can make the liver absorb more "bad" cholesterol from the blood and break it down. NHS patients who have not had a heart attack or stroke but are at a high risk of having one will be invited to take part in the latest trial.